Acceptability of a long‐acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076)-Reference-Cited by-同舟云学术

Acceptability of a long‐acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076)

Published:2019-10 Issue:10 Volume:22 Page:
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Intern AIDS Soc

Author:

Tolley Elizabeth E¹^ORCID,Li Sue²,Zangeneh Sahar Z²,Atujuna Millicent³,Musara Petina⁴,Justman Jessica⁵,Pathak Subash²,Bekker Linda‐Gail³,Swaminathan Shobha⁶,Stanton Jill¹,Farrior Jennifer¹,Sista Nirupama¹

Affiliation:

1. FHI 360 Durham NC USA

2. Vaccine and Infectious Disease Division Fred Hutch Seattle WA USA

3. Desmond Tutu HIV Centre University of Cape Town Cape Town South Africa

4. University of Zimbabwe Harare Zimbabwe

5. Columbia University New York NY USA

6. Rutgers New Jersey Medical School Newark NJ USA

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25408

Reference48 articles.

1. Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients

2. Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States

3. Pre-exposure prophylaxis for HIV prevention in women: current perspectives

4. Perception of HIV Risk and Adherence to a Daily, Investigational Pill for HIV Prevention in FEM-PrEP

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Open Letter on Advancing HIV prevention: Augmenting an ecosystem-based approach to understand prevention decision-making;Gates Open Research;2024-08-02

2. Simultaneous quantification of five antiretrovirals in human tissues using ultra-high performance liquid chromatography-tandem mass spectrometry methods for therapeutic drug monitoring at the sites of action;Journal of Chromatography B;2024-07

3. User Preferences on Long-Acting Pre-Exposure Prophylaxis for HIV Prevention in Sub-Saharan Africa: A Scoping Review;2024-04-02

4. Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for therapeutic monitoring;Journal of Pharmaceutical and Biomedical Analysis;2024-03

5. Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method for quantifying lenacapavir plasma concentrations: Application to therapeutic monitoring;Journal of Chromatography B;2023-11